Key Takeaways
- • The London Borough of Lambeth Pension Fund has committed capital to Schroders Capital's UK Innovation LTAF, bringing total local government pension scheme allocations to over £68 million since the fund's first close last year.
- • Schroders Capital's UK Innovation LTAF has surpassed £100 million in deployed capital across 19 investments, demonstrating accelerated deployment velocity for one of the UK's earliest long-term asset fund structures focused on venture capital.
- • The LTAF raised £500 million at first close with backing from institutional investors including the British Business Bank and Future Growth Capital (a Schroders-Standard Life joint venture), targeting defined contribution pension schemes seeking early-stage UK exposure.
- • The portfolio spans 19 companies across technology and life sciences, including artificial intelligence, fintech, and clinical-stage biopharmaceutical firms, combining direct investments with primary and secondary commitments to venture managers.
- • The strategy provides DC pension schemes and institutional investors direct access to early-stage UK venture capital returns, addressing a structural gap in pension fund participation in high-growth UK innovation ecosystems.
Summary
Schroders Capital's UK Innovation Long Term Asset Fund has achieved meaningful traction among local government pension schemes, with the London Borough of Lambeth Pension Fund joining a cohort of LGPS allocators that have committed more than £68 million to the vehicle since its initial close. This commitment has driven the LTAF past the £100 million deployed capital milestone across 19 portfolio investments, signaling accelerating deployment activity for a nascent UK venture capital vehicle designed specifically for institutional pension investors.
The LTAF itself raised £500 million at first close, supported by backing from the British Business Bank and Future Growth Capital, a joint venture between Schroders and Standard Life. The fund was structured to address a specific market need: enabling defined contribution pension schemes and other institutional investors to gain access to early-stage UK companies without requiring direct venture capital expertise or infrastructure. The vehicle combines direct equity investments alongside primary and secondary commitments to venture managers, providing diversified exposure across the venture ecosystem.
The portfolio reflects broad sector coverage across innovation-focused domains. Current investments span artificial intelligence, fintech, and biopharmaceuticals, encompassing both software companies and clinical-stage biotech firms. Harry Raikes, head of UK venture investments at Schroders Capital, emphasized the firm's venture capital track record spanning nearly three decades and cited the strength of its partner network as enabling differentiated access to high-impact founders and fund managers. He noted that the fund seeks exposure to companies addressing enduring social needs, from medical research through to critical industrial infrastructure.
The LGPS backing represents a significant institutional validation of the LTAF structure at a moment when UK policymakers have prioritized channeling pension capital toward domestic innovation and growth. The £68 million LGPS allocation demonstrates pension fund appetite for UK venture exposure when presented through professionally managed, long-term structures. The move also aligns with broader regulatory initiatives—including the UK Chancellor's endorsement of the LTAF—aimed at mobilizing workplace and public pension capital toward venture-backed UK companies.
The deployment pace over the initial year since first close—moving from £500 million raised to over £100 million deployed across 19 companies—suggests institutional investors are comfortable with Schroders Capital's investment pace and manager selection discipline. For institutional allocators, the LTAF model offers a standardized entry point to UK venture exposure while outsourcing both manager selection and portfolio construction to an established asset manager with long-standing pension fund relationships.
The LTAF itself raised £500 million at first close, supported by backing from the British Business Bank and Future Growth Capital, a joint venture between Schroders and Standard Life. The fund was structured to address a specific market need: enabling defined contribution pension schemes and other institutional investors to gain access to early-stage UK companies without requiring direct venture capital expertise or infrastructure. The vehicle combines direct equity investments alongside primary and secondary commitments to venture managers, providing diversified exposure across the venture ecosystem.
The portfolio reflects broad sector coverage across innovation-focused domains. Current investments span artificial intelligence, fintech, and biopharmaceuticals, encompassing both software companies and clinical-stage biotech firms. Harry Raikes, head of UK venture investments at Schroders Capital, emphasized the firm's venture capital track record spanning nearly three decades and cited the strength of its partner network as enabling differentiated access to high-impact founders and fund managers. He noted that the fund seeks exposure to companies addressing enduring social needs, from medical research through to critical industrial infrastructure.
The LGPS backing represents a significant institutional validation of the LTAF structure at a moment when UK policymakers have prioritized channeling pension capital toward domestic innovation and growth. The £68 million LGPS allocation demonstrates pension fund appetite for UK venture exposure when presented through professionally managed, long-term structures. The move also aligns with broader regulatory initiatives—including the UK Chancellor's endorsement of the LTAF—aimed at mobilizing workplace and public pension capital toward venture-backed UK companies.
The deployment pace over the initial year since first close—moving from £500 million raised to over £100 million deployed across 19 companies—suggests institutional investors are comfortable with Schroders Capital's investment pace and manager selection discipline. For institutional allocators, the LTAF model offers a standardized entry point to UK venture exposure while outsourcing both manager selection and portfolio construction to an established asset manager with long-standing pension fund relationships.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.